Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2026
2025
2024
2023
2022
2023
2023-10-09 08:00
Prolight Diagnostics forms Clinical Advisory Board
2023-10-02 08:00
Prolight Diagnostics publishes investor letter for October 2023
Regulatory
2023-09-06 08:00
Merger Market publishes interview with Prolight Diagnostics CEO, Ulf Bladin
2023-08-29 08:00
Prolight Diagnostics publishes half-year report, 2023
Regulatory
MAR
2023-07-28 08:00
Prolight Diagnostics publishes investor letter for July 2023
Regulatory
2023-07-25 08:00
Prolight Diagnostics publishes investor letter for July 2023
Regulatory
2023-07-12 08:00
Prolight Diagnostics showcases breakthrough POC technology at the AACC Annual Scientific Meeting & Clinical Lab Expo
Regulatory
2023-06-13 08:00
Prolight Diagnostics shows proof-of-performance for high-sensitive troponin
Regulatory
MAR
2023-05-30 09:05
BioStock Life Science Spring Summit with Prolight Diagnostics
2023-05-11 17:40
Prolight Diagnostics publishes quarterly report Q1, 2023
Regulatory
MAR
Previous
Next
